annb0t
Top 20
Immutep Limited
Expansion of the efti clinical development pipeline with a new Phase II setting Efti Phase II trial awarded â¬1.5M (~A$2.2M) in funding as part of the Polish Medical Research Agency program funded by the Polish government Collaboration with the Maria SkÅodowska-Curie National Research Institute to evaluate efti in triple combination with Keytruda (pembrolizumab) and radiotherapy, followed by surgery First patient dose anticipated by H1 2023
SYDNEY, AUSTRALIA, Sept. 06, 2...
>>> Read more: Immutep Announces Investigator-Initiated Phase II Trial Evaluating LAG-3 Candidate Eftilagimod Alpha (Efti) in Soft Tissue Sarcoma
Expansion of the efti clinical development pipeline with a new Phase II setting Efti Phase II trial awarded â¬1.5M (~A$2.2M) in funding as part of the Polish Medical Research Agency program funded by the Polish government Collaboration with the Maria SkÅodowska-Curie National Research Institute to evaluate efti in triple combination with Keytruda (pembrolizumab) and radiotherapy, followed by surgery First patient dose anticipated by H1 2023
SYDNEY, AUSTRALIA, Sept. 06, 2...
>>> Read more: Immutep Announces Investigator-Initiated Phase II Trial Evaluating LAG-3 Candidate Eftilagimod Alpha (Efti) in Soft Tissue Sarcoma
